Pharma
Will unitary Supplementary Protection Certificates (SPCs) follow the introduction of the Unitary Patent (UP) and the Unified Patent Court (UPC)?
SPCs are national rights that apply to certain pharmaceutical and plant protection products that have been authorized for use by the regulatory authorities. Will they follow the introduction of the UP/UPC?
CRISPR: Broad Institute win latest patent battle
The Broad Institute of MIT and Harvard (‘Broad’) have won the latest round in the ongoing battle over patents relating to the gene editing technology, CRISPR.
A brief guide to patenting surgical inventions in Europe
European patent attorney Andrew Mullins looks at patenting surgical inventions.
Protecting IP in lab-grown organs – organoids
Lab-grown miniature organs (also known as organoids) is a technology area that has the potential to significantly lower costs and failure rates in drug development, and to improve safety.
Who are the players in the digital healthcare space for medicine development? An analysis of patent filing trends
In this article, we look at some of the recent patenting trends and challenges in the digital healthcare space, with a spotlight on digital healthcare for medicine development.
G2/21 – Plausibility
A new EPO referral to the enlarged BoA will determine whether post-filed data can be used to support inventive step and plausibility.
